Amount Per Serving
Freijy, T
Impacts to the big pharma's immunology portfolio strategy
2022;15:1430 Lewis AL, McEntee N, Holland J, Patel A
#Pharma #TopSellingDrugs #Biopharma #HealthcareInnovation #Oncology #Immunotherapy #ObesityCare #GLP1 #DrugDevelopment #PharmaceuticalIndustry #MarketInsights #PrecisionMedicine #HealthcareTrends 2025 Pharma Trends: Keytruda, Mounjaro, Ozempic Dominate Top-Selling Drugs : The pharmaceutical industry in 2025 is being dominated by breakthrough therapies across oncology, metabolic disorders, immunology, and cardiovascular care
Despite significant progress observed in clinical trial development, there remains a scarcity of published clinical data, particularly regarding long-term safety, efficacy across diverse populations, and real-world effectiveness